MALVERN, Pa., Jan. 09, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical ...

Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We really hate to see fellow investors lose their hard-earned money. Spare a thought for those who held ...

Management projects "revenue growth of at least 8% over 2025 with Q1 2026 revenue of approximately $18.5 million." Koblish explained the guidance: "Given the change that we've implemented -- wholesale ...

"Last quarter, we laid out a framework detailing the decisive steps we have taken to reset our commercial strategy, and Q1 results show early proof points that our strategic plan is working," said CEO ...

TELA Bio TELA shares are trading lower after the company priced a 4.75 million share offering at $9.50 per share. What Happened: On Tuesday after market closure, TELA Bio announced a public offering ...